Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics

Molecular radiotherapy, or targeted radionuclide therapy, uses systemically administered drugs bearing a suitable radioactive isotope, typically a beta emitter. These are delivered via metabolic or other physiological pathways to cancer cells in greater concentrations than to normal tissues. The abs...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, LauraMay, Smith, April-Louise, Aldridge, Matthew D., Foulkes, Jack, Peet, Connie, Wan, Simon, Gains, Jennifer E., Bomanji, Jamshed B., Gaze, Mark N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711590/
https://www.ncbi.nlm.nih.gov/pubmed/33081161
http://dx.doi.org/10.3390/jpm10040174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711590/
https://www.ncbi.nlm.nih.gov/pubmed/33081161
http://dx.doi.org/10.3390/jpm10040174

Ejemplares similares